{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:11:48Z","timestamp":1785787908586,"version":"3.56.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Anhui Institute of Translational Medicine","award":["2021zhyx-C72"],"award-info":[{"award-number":["2021zhyx-C72"]}]},{"name":"Scientific Research Project of Colleges and Universities in Anhui Province","award":["2023AH040076"],"award-info":[{"award-number":["2023AH040076"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,27]]},"abstract":"<jats:p>\n                    Observational studies suggest an association between glioblastoma (GBM) and cardiovascular diseases (CVDs), but a causal relationship remains unestablished. This study aimed to investigate the causal link between multiple CVDs and GBM risk. The inverse variance weighted method indicated that all 18 CVDs had significant causal associations with GBM (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Genetically predicted CVDs were uniformly associated with a lower risk of GBM (odds ratio\u2005&lt;\u20051), identifying them as potential protective factors. Sensitivity analyses confirmed the absence of significant heterogeneity or horizontal pleiotropy, and the MR-Steiger test validated the correct causal direction. This Mendelian randomization (MR) study provides evidence that a range of CVDs are causally associated with a decreased risk of developing GBM. These findings suggest shared biological pathways and offer new insights for understanding GBM etiology. We conducted a 2-sample MR analysis using publicly available genome-wide association study data. GBM was the outcome, and 18 cardiovascular-related traits (including coronary artery disease, myocardial infarction, and venous thromboembolism) were exposures. Instrumental variables were single-nucleotide polymorphisms significantly associated with exposures (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20055\u2005\u00d7\u200510\n                    <jats:sup>\u22128<\/jats:sup>\n                    ). The primary analysis used the inverse variance weighted method, supplemented with MR-Egger, weighted median, and weighted mode methods. Sensitivity analyses, including Cochran\n                    <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                    test, MR-Egger intercept test, leave-one-out analysis, and MR-Steiger directionality test, were performed to ensure robustness.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047765","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:00:11Z","timestamp":1772240411000},"page":"e47765","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The causal relationship between multiple cardiovascular diseases and glioblastoma: A Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"given":"Keyi","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, Anhui, Hefei, P.R. China"},{"name":"Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Anhui, Hefei, P.R. China"},{"name":"Anhui Public Health Clinical Center, Anhui, Hefei, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaotian","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Anhui, Hefei, P.R. China"},{"name":"Anhui Public Health Clinical Center, Anhui, Hefei, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Tian","sequence":"additional","affiliation":[{"name":"Hospital of Nanjing University of Aeronautics and Astronautics, Nanjing, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8500-0879","authenticated-orcid":false,"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Anhui, Hefei, P.R. China"},{"name":"Anhui Public Health Clinical Center, Anhui, Hefei, P.R. China"},{"name":"Anhui Provincial Institute of Translational Medicine, Anhui, Hefei, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260413","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review.","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"key":"R2-20260413","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/B978-0-12-802997-8.00023-2","article-title":"Glioblastoma.","volume":"134","author":"Wirsching","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"R3-20260413","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11060-013-1341-x","article-title":"Comorbid conditions associated with glioblastoma.","volume":"116","author":"Fisher","year":"2014","journal-title":"J Neurooncol"},{"key":"R4-20260413","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/neuonc\/noad059","article-title":"Epidemiology, biology, and management of venous thromboembolism in gliomas: an interdisciplinary review.","volume":"25","author":"Jo","year":"2023","journal-title":"Neuro-Oncology"},{"key":"R5-20260413","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10072-023-07160-6","article-title":"Prevalence, characteristics, and risk factors of venous thromboembolism in patients with brain tumor undergoing craniotomy: a meta-analysis.","volume":"45","author":"Zeng","year":"2024","journal-title":"Neurol Sci"},{"key":"R6-20260413","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022.","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R7-20260413","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamacardio.2021.5613","article-title":"Prevalence and trends of coronary heart disease in the United States, 2011 to 2018.","volume":"7","author":"Lee","year":"2022","journal-title":"JAMA Cardiol"},{"key":"R8-20260413","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-33330-0_7","article-title":"Inflammation, frailty and cardiovascular disease.","volume":"1216","author":"Soysal","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"R9-20260413","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis.","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res"},{"key":"R10-20260413","doi-asserted-by":"crossref","first-page":"105325","DOI":"10.1016\/j.chemphyslip.2023.105325","article-title":"Recent advances in regulating lipid metabolism to prevent coronary heart disease.","volume":"255","author":"Du","year":"2023","journal-title":"Chem Phys Lipids"},{"issue":"Suppl 1","key":"R11-20260413","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1038\/sj.jhh.1001345","article-title":"Hypertension and coronary heart disease.","volume":"16","author":"Escobar","year":"2002","journal-title":"J Hum Hypertens"},{"key":"R12-20260413","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/138161282004140213145806","article-title":"The relationship between inflammatory and oxidative stress biomarkers, atherosclerosis and rheumatic diseases.","volume":"20","author":"\u015eerban","year":"2014","journal-title":"Curr Pharm Des"},{"key":"R13-20260413","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","article-title":"The global prevalence of myocardial infarction: a systematic review and meta-analysis.","volume":"23","author":"Salari","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"R14-20260413","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2004-822974","article-title":"Platelets and angiogenesis in malignancy.","volume":"30","author":"Sierko","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"R15-20260413","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10555-014-9498-0","article-title":"Platelets and cancer: a casual or causal relationship: revisited.","volume":"33","author":"Menter","year":"2014","journal-title":"Cancer Metastasis Rev"},{"key":"R16-20260413","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2016-06-720714","article-title":"Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.","volume":"129","author":"Riedl","year":"2017","journal-title":"Blood"},{"key":"R17-20260413","doi-asserted-by":"crossref","first-page":"100101","DOI":"10.1016\/j.xcrm.2020.100101","article-title":"Tumor-educated platelet RNA for the detection and (pseudo)progression monitoring of glioblastoma.","volume":"1","author":"Sol","year":"2020","journal-title":"Cell Rep Med"},{"key":"R18-20260413","doi-asserted-by":"crossref","first-page":"114127","DOI":"10.1016\/j.biopha.2022.114127","article-title":"From degenerative disease to malignant tumors: insight to the function of ApoE.","volume":"158","author":"Miao","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R19-20260413","doi-asserted-by":"crossref","first-page":"176011","DOI":"10.1016\/j.ejphar.2023.176011","article-title":"TCH-165 attenuates cardiac ischaemia\/reperfusion injury by balancing mitochondrial dynamics via increasing proteasome activity.","volume":"957","author":"Gao","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"R20-20260413","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrc.2017.82","article-title":"Genome-wide association studies of cancer: current insights and future perspectives.","volume":"17","author":"Sud","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"R21-20260413","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R22-20260413","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1152\/physrev.00024.2022","article-title":"Genome-wide association studies of cardiovascular disease.","volume":"103","author":"Walsh","year":"2023","journal-title":"Physiol Rev"},{"key":"R23-20260413","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41416-020-01083-1","article-title":"Searching for causal relationships of glioma: a phenome-wide Mendelian randomisation study.","volume":"124","author":"Saunders","year":"2021","journal-title":"Br J Cancer"},{"key":"R24-20260413","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1080\/07853890.2022.2085883","article-title":"A causal relationship between childhood obesity and risk of osteoarthritis: results from a two-sample Mendelian randomization analysis.","volume":"54","author":"Cao","year":"2022","journal-title":"Ann Med"},{"key":"R25-20260413","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R26-20260413","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications.","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur Heart J"},{"key":"R27-20260413","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/sim.3213","article-title":"Comments on \u2018Mendelian randomization: using genes as instruments for making causal inferences in epidemiology\u2019 by Debbie A. Lawlor, R. M. Harbord, J. A. Sterne, N. Timpson and G. Davey Smith, Statistics in Medicine, DOI: 10.1002\/sim.3034.","volume":"27","author":"Ziegler","year":"2008","journal-title":"Stat Med"},{"key":"R28-20260413","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R29-20260413","doi-asserted-by":"crossref","first-page":"908831","DOI":"10.3389\/fimmu.2022.908831","article-title":"Systemic lupus erythematosus and cardiovascular disease: a mendelian randomization study.","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"key":"R30-20260413","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R31-20260413","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"R32-20260413","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R33-20260413","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R34-20260413","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R35-20260413","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00701-023-05544-3","article-title":"Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics.","volume":"165","author":"Chehade","year":"2023","journal-title":"Acta Neurochir"},{"key":"R36-20260413","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.ctrv.2019.101896","article-title":"Molecular targeted therapy of glioblastoma.","volume":"80","author":"Le Rhun","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"R37-20260413","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"R38-20260413","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","article-title":"Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors.","volume":"121","author":"Joseph","year":"2017","journal-title":"Circ Res"},{"key":"R39-20260413","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12944-023-01961-6","article-title":"Role of lipins in cardiovascular diseases.","volume":"22","author":"Ding","year":"2023","journal-title":"Lipids Health Dis"},{"key":"R40-20260413","first-page":"363","article-title":"Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases.","volume":"132","author":"Anoop","year":"2010","journal-title":"Indian J Med Res"},{"key":"R41-20260413","doi-asserted-by":"crossref","first-page":"eabd7522","DOI":"10.1126\/scitranslmed.abd7522","article-title":"APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function.","volume":"13","author":"Xiong","year":"2021","journal-title":"Sci Transl Med"},{"key":"R42-20260413","first-page":"299","article-title":"Management of glioblastoma: State of the art and future directions.","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R43-20260413","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.thromres.2015.11.027","article-title":"Recurrent venous thromboembolism in glioblastoma.","volume":"137","author":"Edwin","year":"2016","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"R44-20260413","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0049-3848(13)70024-0","article-title":"Mechanisms of thrombosis in cancer.","volume":"131","author":"Falanga","year":"2013","journal-title":"Thromb Res"},{"key":"R45-20260413","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","article-title":"Mechanisms and risk factors of thrombosis in cancer.","volume":"118","author":"Falanga","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R46-20260413","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis.","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R47-20260413","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/ijms18061321","article-title":"Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction.","volume":"18","author":"Achari","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R48-20260413","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/jcp.24582","article-title":"Adiponectin as novel regulator of cell proliferation in human glioblastoma.","volume":"229","author":"Porcile","year":"2014","journal-title":"J Cell Physiol"},{"key":"R49-20260413","doi-asserted-by":"crossref","first-page":"1113111","DOI":"10.3389\/fgene.2023.1113111","article-title":"Circulating adipokine concentrations and the risk of venous thromboembolism: a Mendelian randomization and mediation analysis.","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Genet"},{"key":"R50-20260413","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.3892\/or.2017.5589","article-title":"AdipoR1-mediated miR-3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK\/SIRT1 pathway.","volume":"37","author":"Liu","year":"2017","journal-title":"Oncol Rep"},{"key":"R51-20260413","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40001-021-00496-9","article-title":"AdipoR2 inhibits human glioblastoma cell growth through the AMPK\/mTOR pathway.","volume":"26","author":"Jie","year":"2021","journal-title":"Eur J Med Res"},{"key":"R52-20260413","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/acs.biochem.8b00579","article-title":"Small molecule modulation of proteasome assembly.","volume":"57","author":"Njomen","year":"2018","journal-title":"Biochemistry"},{"key":"R53-20260413","doi-asserted-by":"crossref","first-page":"101070","DOI":"10.1016\/j.gendis.2023.06.037","article-title":"The role of proteasomes in tumorigenesis.","volume":"11","author":"Zhou","year":"2024","journal-title":"Genes Dis"},{"key":"R54-20260413","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/blood-2005-04-1425","article-title":"C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen.","volume":"107","author":"Lasser","year":"2006","journal-title":"Blood"},{"key":"R55-20260413","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amjms.2020.05.036","article-title":"C1q\/TNF-related protein 1, a multifunctional adipokine: an overview of current data.","volume":"360","author":"Janowska","year":"2020","journal-title":"Am J Med Sci"},{"key":"R56-20260413","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1215\/15228517-2008-117","article-title":"MRI assessment of hemodynamic effects of angiopoietin-2 overexpression in a brain tumor model.","volume":"11","author":"Valable","year":"2009","journal-title":"Neuro-Oncology"},{"key":"R57-20260413","first-page":"631","article-title":"[Influence of heart rate\u2019s circadian rhythm in postoperation of intracerebral hemorrhage with different surgery].","volume":"39","author":"Guan","year":"2008","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"R58-20260413","doi-asserted-by":"crossref","first-page":"921306","DOI":"10.3389\/fgene.2022.921306","article-title":"CircSMARCA5: a key circular RNA in various human diseases.","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Genet"},{"key":"R59-20260413","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3171\/2011.4.JNS101172","article-title":"Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.","volume":"115","author":"Yang","year":"2011","journal-title":"J Neurosurg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:17:14Z","timestamp":1785784634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047765","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"2025-08-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}